Xenetic Biosciences Inc (XBIO)
3.72
+0.17
(+4.79%)
USD |
NASDAQ |
May 17, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
Xenetic Biosciences Revenue (Quarterly): 0.5108M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.5108M |
| December 31, 2023 | 0.672M |
| September 30, 2023 | 0.6112M |
| June 30, 2023 | 0.651M |
| March 31, 2023 | 0.6058M |
| December 31, 2022 | 0.487M |
| September 30, 2022 | 0.4143M |
| June 30, 2022 | 0.4167M |
| March 31, 2022 | 0.389M |
| December 31, 2021 | 0.3326M |
| September 30, 2021 | 0.3493M |
| June 30, 2021 | 0.2876M |
| March 31, 2021 | 0.1912M |
| December 31, 2020 | 0.1513M |
| September 30, 2020 | 0.1159M |
| June 30, 2020 | 0.1129M |
| March 31, 2020 | 0.0567M |
| December 31, 2019 | 0.0171M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | 7.50M |
| September 30, 2017 | 0.085M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 3.00M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| November 30, 2013 | 0.0022M |
| August 31, 2013 | -0.008M |
| May 31, 2013 | 0.0394M |
| February 28, 2013 | 0.0326M |
| November 30, 2012 | 0.033M |
| August 31, 2012 | 0.0266M |
| May 31, 2012 | 0.0364M |
| February 29, 2012 | 0.036M |
| November 30, 2011 | 0.0137M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0171M
Minimum
Dec 2019
0.672M
Maximum
Dec 2023
0.354M
Average
0.3691M
Median
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 13.87M |
| Xtant Medical Holdings Inc | 27.87M |
| Asensus Surgical Inc | 1.123M |
| Myomo Inc | 3.754M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.195M |
| Total Expenses (Quarterly) | 1.779M |
| EPS Diluted (Quarterly) | -0.78 |
| Enterprise Value | -2.263M |
| Profit Margin (Quarterly) | -234.0% |
| Earnings Yield | -81.21% |
| Normalized Earnings Yield | -81.21 |